• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT SYPHILIS TP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT SYPHILIS TP Back to Search Results
Catalog Number 08D06-77
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/29/2020
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product, architect syphilis tp, list 8d06-39, that has a similar product distributed in the us, list number 8d06-31/-41.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Section a patient information: no specific patient information was provided.
 
Event Description
The customer obtained (b)(6) architect syphilis tp results.Sample id (b)(6) generated (b)(6) and retest (b)(6).The sample generated (b)(6) results on fuji agglutination method and another abbott platform ((b)(6)).No impact to patient management was reported.
 
Manufacturer Narrative
The following fields were corrected within section d suspect medical device: d2 product code changed from mtn to lip d4 catalogue number changed from 08d06-39 to 08d06-77; lot# changed from 07415be000 to 07415be01; and gtin was changed from 00380740103569 to blank.An evaluation is still in process.A follow-up report will be submitted when the evaluation is complete.
 
Manufacturer Narrative
Review of complaint activity determined that there was normal complaint activity for reagent lot 07415be01.Review of tracking and trending reports did not identify any related trends for the architect syphilis tp assay.A retained reagent kit of the complaint lot was tested in a sensitivity setup.No false non-reactive results were obtained, indicating that the sensitivity performance is not negatively impacted.A review of the manufacturing documentation for the reagent did not identify any issues associated with the complaint issue.Additionally, labeling was reviewed and sufficiently addresses the customer's issue.No systemic issue or deficiency of the architect syphilis tp reagent was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT SYPHILIS TP
Type of Device
SYPHILIS
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key10045057
MDR Text Key191243125
Report Number3002809144-2020-00390
Device Sequence Number1
Product Code LIP
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 07/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/08/2020
Device Catalogue Number08D06-77
Device Lot Number07415BE01
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/29/2020
Initial Date FDA Received05/11/2020
Supplement Dates Manufacturer Received05/26/2020
06/29/2020
Supplement Dates FDA Received06/10/2020
07/01/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR, LIST 03M74-02.; ARCHITECT I2000SR, LIST 03M74-02.; ARCHITECT I2000SR, LIST 03M74-02.; SERIAL (B)(6).; SERIAL (B)(6).; SERIAL (B)(6).
-
-